Antinociception produced by ADL 10-0101, a novel peripheral kappa opioid receptor agonist, in models of inflammatory hyperalgesia
Gottshall, S.L.; Cassel, J.A.; Cortes Burgos, L.; Daubert, J.D.; Dehaven, R.N.; Koblish, M.; Kumar, V.; Little, P.J.; Long, S.L.; Marella, M.; Dehaven Hudkins, D.L.
Society for Neuroscience Abstracts 25(1-2): 1221
1999
ISSN/ISBN: 0190-5295 Accession: 034422586
PDF emailed within 1 workday: $29.90
Related References
Eliav, E.; Herzberg, U.; Caudle, R.M. 1999: The kappa opioid agonist GR89,696 blocks hyperalgesia and allodynia in rat models of peripheral neuritis and neuropathy Pain 79(2-3): 255-264Amarante, L.H.; Alves, D.P.; Duarte, I.D.G. 2004: Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine European Journal of Pharmacology 494(2-3): 155-160
Mercado-Reyes, J.; Almanza, A.él.; Segura-Chama, P.; Pellicer, F.; Mercado, F. 2019: D2-like receptor agonist synergizes the μ-opioid agonist spinal antinociception in nociceptive, inflammatory and neuropathic models of pain in the rat European Journal of Pharmacology 853: 56-64
da Fonseca Pacheco, D.; Klein, A.; de Castro Perez, A.; da Fonseca Pacheco, C.M.; de Francischi, J.N.; Duarte, I.D.G. 2008: The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors British Journal of Pharmacology 154(5): 1143-1149
Zhang, R.; Xu, B.; Zhang, Q.; Chen, D.; Zhang, M.; Zhao, G.; Xu, K.; Xiao, J.; Zhu, H.; Niu, J.; Li, N.; Fang, Q. 2020: Spinal administration of the multi-functional opioid/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia European Journal of Pharmacology 880: 173169
Li, N.; Han, Z.-L.; Xu, B.; Zhang, M.-N.; Zhang, T.; Shi, X.-R.; Zhao, W.-D.; Guo, Y.-Y.; Zhang, Q.-Q.; Fang, Q. 2018: Systemic administration of the bifunctional opioid/neuropeptide FF receptors agonist BN-9 produced peripheral antinociception in preclinical mouse models of pain European Journal of Pharmacology 837: 53-63
Tseng, L.F.; Collins, K.A.; Narita, M.; Kampine, J.P. 1995: Antisense oligodeoxynucleotide to opioid kappa receptor mRNA selectively blocks the spinal kappa-1 agonist antinociception in the mouse FASEB Journal 9(3): A97
Gottshall, S.L.; Dehaven Hudkins, D.L. 1997: Effects of peripheral administration of delta opioid receptor agonists in models of inflammatory hyperalgesia Society for Neuroscience Abstracts 23(1-2): 1018
Pacheco, D.d.F.; Klein, A.é; Perez, A.éa.C.; Pacheco, C.M.d.F.; de Francischi, J.N.; Reis, G.áu.M.L.; Duarte, I.D.G. 2009: Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor British Journal of Pharmacology 158(1): 225-231
Hunter, J.C.; Atwal, P.; Woodruff, G.N.; Singh, L. 1994: Differential modulation of kappa and mu opioid antinociception by the glycine/NMDA receptor agonist D-serine British Journal of Pharmacology 112(4): 1002-1003
Amarante, L.H.; Duarte, I.D.G. 2002: The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway European Journal of Pharmacology 454(1): 19-23
Wang, Y.; Hackel, D.; Peng, F.; Rittner, H.L. 2013: Long-term antinociception by electroacupuncture is mediated via peripheral opioid receptors in free-moving rats with inflammatory hyperalgesia European Journal of Pain 17(10): 1447-1457
Wu, H-en.; Sun, H-Sen.; Terashivili, M.; Schwasinger, E.; Sora, I.; Hall, F.Scott.; Uhl, G.R.; Tseng, L.F. 2006: dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice European Journal of Pharmacology 531(1-3): 103-107
Picolo, G.; Giorgi, R.; Cury, Y. 1998: Evidence that antinociception induced by Crotalus durissus terrificus venom on inflammatory hyperalgesia is partially mediated by peripheral opioid receptors Toxicon 36(9): 1305
Ohsawa, M.; Kamei, J. 2005: Modification of kappa-opioid receptor agonist-induced antinociception by diabetes in the mouse brain and spinal cord Journal of Pharmacological Sciences 98(1): 25-32